Newton Biocapital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Synergiasynergia-medical.comSep 2022
Synergia Medical develops optoelectronic implantable medical devices, including its NAO.VNS vagus nerve stimulation system, which is undergoing First-In-Human clinical evaluation through the AURORA study.
Deep TechHealthtechMedical DevicesBrussels, BE
Charles Nolet(CEO)inVincent De Rudder(VP QARA)Gijs Klarenbeek(VP of Clinical)Dan Scherrer(COO)inDimitri Crelot(CFO)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.